CEO: Brian Lian

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Capital Market

Country: USA

Description: Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.


Key numbers

Market Capitalization:578834640
Shares Outstanding: 72264000
Float: 64429137.11999999
Next Earning Date:2020-03-11
TTm EPS: -0.3283
TTm Dividend Rate:
200 days moving average:7.89
50 days moving average: 7.01
One day percent Change: 4.95



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,